Heterologous expression method of coding gene of p-hydroxyphenylpyruvate dioxygenase, melanin product of coding gene and application of melanin product
By heterologously expressing hydroxyphenylpyruvate dioxygenase in Escherichia coli, the recombinant strain BL21-pET28a-hppd was constructed, and the efficient production of melanin was successfully achieved, which solved the problem of limited melanin raw materials in natural animals and plants, and reduced production and demonstrate its protective effect under ultraviolet light.
Patent Information
- Application Number
- CN202410905440.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-05
AI Technical Summary
The raw materials for extracting melanin from natural animals and plants are limited and costly, making it difficult to achieve large-scale production.
By achieving heterologous expression of hydroxyphenylpyruvate dioxygenase in Escherichia coli, the recombinant strain BL21-pET28a-hppd was constructed using genetic engineering technology, and the hydroxyphenylpyruvate dioxygenase gene was induced to express hydroxyphenylpyruvate dioxygenase gene was synthesized Highly efficient melanin.
It realizes efficient production of melanin, reduces production costs, improves economic benefits, and demonstrates the stability of melanin on light intensity and the ultraviolet protection effect on bacteria.
Smart Images

Figure CN118895284A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of synthetic biology and fermentation engineering, relates to the application of synthetic biology technology, and specifically relates to a heterologous expression method of a gene encoding p-hydroxyphenylpyruvate dioxygenase, its product melanin and application thereof. Background Art
[0002] 4-Hydroxyphenylpyruvate dioxygenase (HPPD) belongs to the non-heme oxygenase class and is iron (II)-dependent and α-ketoacid-dependent. It is a key enzyme involved in tyrosine metabolism. Under aerobic conditions, it catalyzes the conversion of 4-hydrophenylpyruvate (HPP) into homogentisate (HGA), while releasing CO 2 , this process includes oxidative decarboxylation, aromatic ring hydroxylation, and 1,2 displacement of the carboxyl group. In mammals and humans, tyrosine can be converted into fumaric acid and acetoacetic acid. Fumaric acid enters the tricarboxylic acid cycle, and acetoacetic acid is activated by succinic-CoA to form acetoacetyl-CoA. Genetic defects in the tyrosine metabolic pathway lead to tyrosinemia. Among them, patients with tyrosinemia genetic disease who lack homogentisate-1,2-dioxygenase will accumulate a large amount of homogentisate in their urine. When the urine is exposed to oxygen, it turns black because homogentisate undergoes spontaneous oxidation and polymerization to form a melanin-like substance. In plants, HGA produced by HPP under HPPD catalysis is an important substance that can be further decarboxylated, polyprenylated, and alkylated to produce plastoquinone and tocopherol.
[0003] Melanin is a kind of phenolic or indole polymer with extremely complex chemical structure and heterogeneity. According to the different synthesis pathways and intermediate metabolites, melanin can be mainly divided into three categories: eumelanin, pheomelanin, and allomelanin. It is widely present in different biological groups including animals, plants and microorganisms. Studies have shown that most organisms synthesize melanin under adverse environmental conditions. Bacteria usually synthesize "eumelanin" based on dihydroxyphenylalanine (DOPA) or "pyomelanin" based on homogentisate (HGA). Eumelanin and pheomelanin are collectively called dopa melanin because they mainly convert monophenolic substances such as tyrosine into melanin through the action of polyphenol oxidases such as tyrosinase or laccase. The detection of the presence of the intermediate product L-DOPA is one of the signs of this pathway. The difference between pheomelanin and eumelanin is that cysteine participates in the reaction in the pigment formation process of the former. L-DOPA is first cyanided and then polymerized to form a sulfur-containing pigment that is red or yellow. Isomerans include pyomelanocin and 1,8-dihydroxynaphthalene (DHN) melanin. DHN melanin is synthesized through the DHN pathway using malonyl-CoA as a substrate. Pyomelanocin is also known as homogentisate melanin because homogentisate (HGA) is a characteristic intermediate in the pigment synthesis pathway. HGA is formed by the substrate 4-hydroxyphenylpyruvate (4-hydrophenylpyruvate) catalyzed by 4-hydrophenylpyruvate dioxygenase (HPPD) in the tyrosine metabolic pathway. Fumarate and acetoacetate are then synthesized by homogentisate 1,2-dioxygenase and others, and the latter eventually generates pyomelanocin through spontaneous oxidation and polymerization reactions.
[0004] Most species of organisms in nature have a melanin synthesis pathway. There is a close connection between the synthesis of melanin and the survival, evolution and tolerance of organisms to adverse environmental conditions. Melanin has the property of light absorption, so the synthesis and existence of melanin have a photoprotective effect on organisms, enabling them to tolerate ultraviolet radiation. The surface melanin of some animals also has the function of regulating body temperature. Melanin also has the antioxidant property of scavenging reactive oxygen free radicals and can protect DNA from oxidative degradation. At the same time, melanin helps to resist the host immune response and enhance the virulence of pathogens. Melanin can chelate heavy metal ions and protect the body from heavy metal poisoning. Based on the physiological functions of melanin such as ultraviolet absorption, anti-oxidation, and biosafety, melanin has been widely used as an additive in cosmetics, food, and biosafety dyes. In addition, levodopa is an intermediate product of melanin metabolism and synthesis, and plays a special role in the clinical treatment of Parkinson's disease.
[0005] Plant-derived melanin is mainly isomelanin, while animal-derived melanin is mainly eumelanin, which can be extracted from black-bone chickens, black-bone sheep and cephalopod marine organisms. Most melanin from both sources forms complexes with polysaccharides and proteins in tissues, making them difficult to purify. In addition, due to the limited animal and plant resources, it is difficult to achieve large-scale production of melanin from these sources. Currently, the most promising way to produce melanin is through microbial synthesis. This is a more environmentally friendly and low-cost synthesis pathway that is conducive to scaled-up production. Summary of the invention
[0006] The present invention aims at the problems and shortcomings of limited raw materials and high cost for extracting melanin from natural animals and plants, and provides a heterologous expression method of p-hydroxyphenylpyruvate dioxygenase and a melanin preparation method, which realizes efficient production of melanin in Escherichia coli through the heterologous expression pathway.
[0007] The present invention provides a gene encoding hydroxyphenylpyruvate dioxygenase, wherein the nucleotide sequence of the gene is SEQ ID NO.1, denoted as hppd 1071 .
[0008] Preferably, the amino acid sequence of the p-hydroxyphenylpyruvate dioxygenase is SEQ ID NO.2 or a nonsense mutation sequence thereof.
[0009] Preferably, the gene encoding the p-hydroxyphenylpyruvate dioxygenase is derived from fungicidal Streptomyces.
[0010] Preferably, the fungicidal Streptomyces is Streptomyces fungicidicus NW-EN1.
[0011] The second aspect of the present invention provides a genetic engineering expression vector, wherein the expression vector is integrated with a nucleic acid fragment of the gene encoding the p-hydroxyphenylpyruvate dioxygenase.
[0012] Preferably, the genetic engineering expression vector is recombinant pET-28a(+).
[0013] The third aspect of the present invention provides a genetically engineered bacterium, wherein the genetically engineered bacterium carries the expression vector.
[0014] Preferably, the genetically engineered bacteria is recombinant Escherichia coli BL21 (DE3).
[0015] Preferably, the Escherichia coli BL21 (DE3) is a BL21-pET28a-hppd strain.
[0016] A fourth aspect of the present invention is a method for preparing melanin, wherein the method comprises preparing melanin by fermenting the genetically engineered bacteria according to claim 9.
[0017] Preferably, the method comprises the following steps:
[0018] (1) Activating the genetically engineered bacteria, inoculating them into the fermentation medium, and culturing them at 37° C. for 2 h;
[0019] (2) IPTG was added and induced at 20°C for 48 h.
[0020] Preferably, in the step (2), the amount of IPTG added is 1 mM, which is used to induce heterologous expression of p-hydroxyphenylpyruvate dioxygenase.
[0021] Preferably, in step (1), the fermentation medium is supplemented with 1 g / L L-tyrosine and 1 mM Cu 2+ .
[0022] The fifth aspect of the present invention provides a melanin prepared by the above method.
[0023] Preferably, the melanin is pyomelanopic pigment.
[0024] The sixth aspect of the present invention provides an application of the melanin in the stability of light intensity and the protective effect on bacteria under ultraviolet irradiation.
[0025] The beneficial effects of the present invention are as follows: (1) the constructed strain can successfully synthesize melanin in LB medium by adding tyrosine exogenously, thereby saving the production cost of melanin and improving economic benefits; (2) the constructed strain used is an engineered strain that can be well applied to actual production, thereby reducing production costs; (3) by inducing the expression of the p-hydroxyphenylpyruvate dioxygenase gene during the fermentation process, the melanin yield reaches a maximum of 804.4±5.9 mg / L at 48 hours of fermentation. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 Schematic diagram of colony PCR verification of recombinant plasmid pET28a-hppd.
[0027] Figure 2 is the standard curve of melanin.
[0028] Figure 3 Infrared spectrum of purified melanin.
[0029] Figure 4 UV-visible spectrum of purified melanin.
[0030] Figures 5a to 5d This is a scanning electron micrograph of purified melanin.
[0031] Figure 6a Schematic diagram of HPLC analysis of LB culture supernatant containing tyrosine.
[0032] Figure 6b Schematic diagram of HPLC analysis of LB medium supernatant containing HGA.
[0033] Figure 6c Schematic diagram of HPLC analysis of the supernatant of BL21-pET28a-hppd cultured at 20°C.
[0034] Figure 7 This is the growth curve of the recombinant bacteria BL21-pET28a-hppd.
[0035] Figure 8 a is a schematic diagram showing the effect of L-tyrosine concentration on the production of pyomelanocortin by BL21-pET28a-hppd.
[0036] Figure 8 b is a schematic diagram of the effect of temperature on the production of pyomelanocortin by BL21-pET28a-hppd.
[0037] Figure 8 c is a schematic diagram of the effect of pH on the production of pyomelanocortin by BL21-pET28a-hppd.
[0038] Figure 8d is a schematic diagram of the effect of metal ions on the production of pyomelanocortin by BL21-pET28a-hppd.
[0039] Fig. 9 Schematic diagram of the UV protection of pyomelanocortin on microorganisms.
[0040] Wherein: Protective effect of pyomelanocin on bacteria (a) and fungi (b): Survival rate of bacteria and yeast in culture medium containing pyomelanocin after ultraviolet irradiation for a period of time. (1) and (2) represent the experimental group with pyomelanocin and the control group without pyomelanocin, respectively. DETAILED DESCRIPTION
[0041] In order to better understand the content of the present invention, the following is further described in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention and are not used to limit the scope of the present invention.
[0042] The first object of the present invention is to provide a heterologous expression method of p-hydroxyphenylpyruvate dioxygenase, using Escherichia coli BL21 (DE3) strain as a chassis microorganism, applying synthetic biology technology, successfully expressing the p-hydroxyphenylpyruvate dioxygenase gene hppd of fungicidal Streptomyces in the BL21 (DE3) strain, and successfully constructing a melanin-producing strain, namely the BL21-pET28a-hppd strain. The strain can synthesize a large amount of melanin mainly composed of pyomelanocortin in a culture medium supplemented with exogenous tyrosine.
[0043] The method for constructing the p-hydroxyphenylpyruvate dioxygenase is specifically cloning and heterologous expression of the p-hydroxyphenylpyruvate dioxygenase gene, firstly extracting the fungicidal streptomyces genome, amplifying the p-hydroxyphenylpyruvate dioxygenase gene hppd by PCR, then constructing it into pET-28a(+) to obtain a recombinant plasmid with the p-hydroxyphenylpyruvate dioxygenase gene, transforming it into a competent cell BL21(DE3), and finally constructing BL21-pET28a-hppd.
[0044] In one embodiment of the present invention, the p-hydroxyphenylpyruvate dioxygenase gene is from fungicidal Streptomyces, and the strain is named Streptomyces fungicidicus NW-EN1.
[0045] In one embodiment of the present invention, the added concentration of the exogenous tyrosine is 1 g / L.
[0046] In one embodiment of the present invention, the recombinant plasmid is pET-28a(+).
[0047] In one embodiment of the present invention, the Escherichia coli BL21 (DE3) is an engineered strain.
[0048] The second object of the present invention is to provide a method for producing melanin by fermentation using an engineered bacterium expressing the gene, specifically, 100 μL of bacterial solution of BL21-pET28a-hppd is drawn from a bacterium-preserving cryopreservation tube, and cultured at 37°C and 200 rpm for 16 hours in 10 mL of seed culture medium (containing 50 μg / L of kanamycin) to obtain a seed solution of the engineered strain. Then, the inoculum is inoculated into a fermentation medium at pH 8.5 at a 1% inoculation amount, cultured at 37°C and 200 rpm for 2 hours, and induced at 20°C and 200 rpm for 48 hours after adding 1 mM IPTG.
[0049] The method, in one embodiment of the present invention, further comprises exogenously adding tyrosine and metal Cu during the fermentation culture. 2+ The amount of tyrosine added is 1g / L, and the metal Cu 2+ The amount added was 1 mM.
[0050] The fourth object of the present invention is to provide pyomelanocortin produced according to the above method.
[0051] The fifth purpose of the present invention is to provide the stability of the pyomelanocin produced according to the above method to light intensity and the protective effect on bacteria under ultraviolet irradiation.
[0052] The present invention is further described below in conjunction with specific embodiments.
[0053] The various determination and analysis methods used in the embodiments of the present invention are as follows:
[0054] Seed medium: peptone 1%; yeast extract 0.5%; NaCl 1%; pH 7.0.
[0055] Fermentation medium: tyrosine 1‰; peptone 1%; yeast extract 0.5%; NaCl 1%; pH 7.0.
[0056] Method for extracting fungicidal Streptomyces genome (refer to the instructions of Generay Bacterial Genomic DNA Rapid Extraction Kit): collect the bacteria in the exponential growth phase, centrifuge for 1 min (12,000 rpm), and discard the supernatant. The following centrifugation is all at this speed; take 150μL TE buffer, add 8μL lysozyme (appropriate amount), mix by blowing; take 300μL Digestion Solution, add, mix by blowing, add RNase A (4μL), and mix again; keep warm at 55℃ for 10min, take 4μL Proteinase K, and keep warm under the same conditions for about 30min (depending on the viscosity of the solution); then take 300μL PB solution and 300μL Ext solution, add, shake evenly, centrifuge for 5min, then the solution in the tube is divided into three layers, use the gun tip to carefully take out the transparent solution in the lower layer and put it into a 2mL collection tube with a GenClean column, and discard the remaining liquid; centrifuge the collection tube for 1min, and discard the remaining liquid; wash the GenClean column twice with 500μL Wash Solution by centrifugation, place the GenClean column in a new 2mL EP tube and centrifuge for 1min to remove the residual Wash Solution; take a clean 1.5mL The EP tube is used as the final collection tube. GenClean is placed in it, and 50-100 μL of Elution Buffer preheated in a 60°C oven is added. Then it is allowed to stand for about 1 minute. After centrifugation for 1 minute, the column is discarded, leaving the solution, which is the genomic DNA extracted from the bacteria.
[0057] Bacterial plasmid extraction method (refer to the instructions of Axygen bacterial plasmid extraction kit):
[0058] The bacteria containing the plasmid in the exponential growth phase were collected, centrifuged for 1 min (12,000 rpm), and the supernatant was discarded. The following centrifugation is at this speed; add 250μL of Buffer S1 solution to the EP tube, and suspend the bacteria by blowing; add 250μL of Buffer S2 solution to the above EP tube, cover it tightly, and slowly invert it 7-8 times using the EP tube rack to observe that the turbid suspension in the tube becomes a clear and transparent solution; then add 350μL of Buffer S3 solution to the EP tube, invert it 8-10 times to mix (slowly), and after centrifugation for 10 minutes, the tube is clearly divided into two layers; carefully aspirate the clear upper layer liquid with a gun tip, transfer it to the 2mL collection tube containing the preparation tube, centrifuge for 1min, and discard the liquid; take out the preparation tube and put it back into the 2mL EP centrifuge tube, take 500μL of Buffer W1 solution into the tube, centrifuge for 1min, and discard the filtrate; put the preparation tube back into the 2mL EP centrifuge tube, add 700μL of Buffer W2 solution, centrifuge for 1min, and discard the liquid. Repeat this step once; put the preparation tube back into the EP tube and leave it empty for 1min. Then place it in an oven for 3-5 minutes to allow the remaining ethanol to evaporate completely; finally, place the preparation tube into a new 1.5mL EP tube, add 60-100μL of Elution Buffer solution (add to the center of the preparation membrane), let it stand at room temperature for 1-2 minutes, and centrifuge it for 1 minute to collect the liquid that is the extracted plasmid DNA.
[0059] The Escherichia coli BL21, DH5α and pET28a vectors used in the following embodiments of the present invention were purchased from Novagen. The primers were all commissioned to be synthesized by Shanghai Shenggong Biotechnology Co., Ltd. The sequencing was commissioned to Shanghai Huada Gene Technology Co., Ltd. The extraction, recovery and purification of plasmid DNA were completed using a bacterial plasmid extraction kit (purchased from Axygen) and a gel recovery kit (purchased from Axygen). Restriction endonucleases were purchased from Takara, Japan. PCR amplification was completed using Taq DNA polymerase (purchased from Takara, Japan), and the reaction system and reaction conditions were set according to the instructions.
[0060] The experimental methods in the following examples of the present invention where specific conditions are not specified are generally carried out under conventional conditions, such as those described in Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989).
[0061] Unless otherwise specified, the raw materials or reagents used in the following examples of the present invention are all commercially available. Unless otherwise specified, % represents weight volume percentage.
[0062] Example 1 Construction of inducible expression vector and engineered strain
[0063] Using the genome of Streptomyces fungicidicus NW-EN1 as a template, the primers shown in Table 1: hppd-BamHI-F (SEQ ID NO.1), hppd-XhoI-R (SEQ ID NO.2) were used to PCR amplify the target gene hppd fragment with restriction sites. The target gene hppd fragment was connected to the double-digested (BamHI, XhoI) linearized vector pET28a using T4 ligase overnight, and transformed into Escherichia coli DH5α competent cells, screened on LB plates containing Kan resistance, and the obtained transformants were verified by colony PCR and restriction digestion to obtain the correct transformants.
[0064]
[0065] After the recombinant plasmid was transformed into E. coli DH5α, the transformants were picked and verified by colony PCR using hppd verification primers, such as Figure 1 The band size is consistent with the theoretical size of hppd (1071 bp), indicating that it is a correct recombinant plasmid.
[0066] The recombinant plasmid was electroporated into Escherichia coli BL21 and screened in a medium containing 50 μg / L Kan. Transformants were picked for colony PCR verification, and the recombinant strain BL21-pET28a-hppd was successfully constructed.
[0067] Example 2 Identification of Melanin Fermentation Products
[0068] 2.1 Standard curve drawing
[0069] Prepare melanin with a concentration of 10g / L, add it to the Ep tube according to the system in the table below, and measure its absorbance at 460nm. 460 The experimental results are shown in Figure 2 shown.
[0070] Reaction system:
[0071]
[0072] 2.2 Cultivation of recombinant strains
[0073] The recombinant strain BL21-pET28a-hppd monoclonal colony constructed in Example 1 was inoculated into 10 ml of seed culture medium containing 50 ug / L kanamycin and cultured overnight at 37° C. The next day, the bacterial solution was transferred to 50 ml of fermentation medium at a 1% inoculum, cultured at 37° C. for 2 h, and induced at 20° C. after adding 1 mM IPTG.
[0074] 2.3 Melanin extraction and purification method
[0075] Induce cell expression at 20°C for 48h, and collect the fermentation broth by centrifugation at 8000rpm for 10 minutes at 4°C to separate cells and supernatant. Treat the supernatant with 6M HCl and adjust the pH to 2.0 to precipitate melanin. After precipitation overnight, centrifuge at 12000rpm for 15min to collect the precipitated melanin and dissolve it in a NaOH solution adjusted to pH 10. The pH value of the solution was adjusted to 2.0 to precipitate the melanin again. The precipitation process was carried out twice. The extracted melanin was finally rinsed three times with distilled water. Melanin powder was prepared by drying at 60°C for 24h and stored at 4°C.
[0076] 2.4 Identification methods of melanin
[0077] The FTIR infrared spectrometer Nicolet 6700 (Thermo Fisher Scientific, USA) was used to measure the -1 Melanin purified from Figure 3 Melanin was analyzed using a UV-1200 spectrophotometer (MAPADA, Shanghai, China), and the UV spectral data of the purified pigment (dissolved in Tris-HCl solution at pH 8.5) were recorded in the wavelength range of 420–600 nm ( Figure 4 Purified pigment samples were analyzed by scanning electron microscopy at different magnifications using a S-3400N scanning electron microscope (Hitachi, Japan). Figures 5a to 5d ). The cell-free supernatant was analyzed by HPLC for the presence of HGA, a precursor substance for the decomposition of L-tyrosine. First, 1 mL of culture medium was taken from all samples and 5 μL of 6M HCl was added thereto. After thorough mixing, the cell-free supernatant was recovered by centrifugation at 12000 rpm for 5 min and filtered through a 0.45 μm syringe filter, and then 10 μL of the sample was injected into the HPLC column for analysis of HGA. The HPLC conditions for HGA are as follows: ZORBAX EclipseXDB C18, column temperature 30°C, mobile phase: acetonitrile: water 20:80 (v / v, 0.1% acetic acid), flow rate 0.5 mL / min. The detection wavelength is 290 nm ( Figure 6a-6c ).
[0078] 2.5 Melanin production determination method
[0079] Since melanin has a maximum absorption wavelength at 460nm, the calculation is performed based on the absorbance of the sample at 460nm and the standard curve of melanin concentration. The fermentation broth taken at different time points was centrifuged at 8000rpm for 10min, the supernatant was taken and the absorbance at 460nm was measured with a UV-visible photometer, and the concentration of melanin was calculated based on the standard curve.
[0080] 2.6 Biomass determination method
[0081] Dilute the samples at each sampling point to an appropriate multiple, until OD 600 The value is 0.2-0.8, 200 μL is measured, and the absorbance is measured at a wavelength of 600 nm using a UV-visible photometer. The growth curve of the recombinant bacteria is shown in Figure 7 shown.
[0082] Example 3 Optimization of melanin fermentation conditions
[0083] The recombinant strain BL21-pET28a-hppd constructed in Example 1 was inoculated into 1% (v / v) seed culture medium and cultured overnight. Afterwards, the culture solution was diluted 100 times and cultured under different culture conditions of the fermentation medium (pH 6.5-9.0, L-tyrosine concentration 0-2 g / L and different metal ions). When OD 600 When the concentration of IPTG in the culture medium was 0.6-0.8, a final concentration of 0.5 mM IPTG was added and the cells were cultured at 200 rpm at different induction temperatures (10-37°C). The melanin concentration was measured after 48 h of culture. The melanin production results under different conditions are shown in Figure 2. Figure 8 shown.
[0084] Example 4 Application of pyomelanocin in bacterial cell protection
[0085] E. coli and yeast were inoculated into small tubes and cultured on a shaker at 37°C and 28°C for 24 h and 36 h, respectively. The concentration of E. coli and yeast in the plate was adjusted to 10 8 cells / mL, and add 100mg / L melanin solution. For the control group, add sterile water instead of melanin solution. Irradiate at 30cm under ultraviolet light (10W). At regular intervals, take out 0.1mL from the plate, dilute to appropriate concentration and apply to solid culture medium. Repeat 3 times. After 24 hours of culture, count the number of colonies to calculate the survival rate. The experimental results are as follows Fig. 9 shown.
[0086] In this specification, the present invention has been described with reference to specific embodiments thereof. However, it is apparent that various modifications and variations may be made without departing from the spirit and scope of the present invention. Therefore, the specification and drawings should be regarded as illustrative rather than restrictive.
Claims
1. A gene encoding p-hydroxyphenylpyruvate dioxygenase, characterized in that: The gene nucleotide sequence is SEQ ID NO.1, recorded as hppd 1071 .
2. The gene encoding p-hydroxyphenylpyruvate dioxygenase according to claim 1, characterized in that The amino acid sequence of the p-hydroxyphenylpyruvate dioxygenase is SEQ ID NO. 2 or its nonsense mutation sequence.
3. The gene encoding p-hydroxyphenylpyruvate dioxygenase according to claim 1, characterized in that The encoding gene of the p-hydroxyphenylpyruvate dioxygenase is derived from fungicidal Streptomyces.
4. The gene encoding p-hydroxyphenylpyruvate dioxygenase according to claim 3, characterized in that The fungicidal Streptomyces is Streptomyces fungicidicus NW-EN1.
5. A genetic engineering expression vector, characterized in that: The expression vector is integrated with the nucleic acid fragment of the gene encoding the p-hydroxyphenylpyruvate dioxygenase according to claim 1.
6. The genetic engineering expression vector according to claim 5, characterized in that The genetic engineering expression vector is recombinant pET-28a(+).
7. A genetically engineered bacterium, characterized in that: The genetically engineered bacteria carries the expression vector according to claim 5.
8. The genetically engineered bacterium according to claim 7, characterized in that The genetically engineered bacteria is recombinant Escherichia coli BL21 (DE3).
9. The genetically engineered bacterium according to claim 8, characterized in that The Escherichia coli BL21 (DE3) is a BL21-pET28a-hppd strain.
10. A method for preparing melanin, characterized in that: The method comprises fermenting the genetically engineered bacteria according to claim 9 to prepare melanin.
Citation Information
Patent Citations
EP60-100
Cited By
Construction method and application of Zymomonas mobilis recombinant strain for producing melanin
CN120536329A
A method for constructing a recombinant strain of *Mammotrophic motility-producing* and its application
CN120536329B
